Please provide your email address to receive an email when new articles are posted on . Ovaprene, a monthly hormone-free contraceptive, blocked motile sperm in an early-phase study. There were no ...
Please provide your email address to receive an email when new articles are posted on . Levonorgestrel-releasing intrauterine system users vs. nonusers had an increased risk for breast cancer. Breast ...
Newly issued patent covers a new medical device and method to deliver and remove hydrogel within the body, including Plan A™’s sperm occlusion system. We have been thoughtfully innovating for several ...
Dublin, Feb. 26, 2026 (GLOBE NEWSWIRE) -- The "Contraceptive Drug Eluting Devices Market - Global Forecast 2026-2032" report has been added to ResearchAndMarkets.com's offering. The global ...
Why should women in British Columbia, Manitoba, Prince Edward Island and the Yukon have access to free contraception while the rest of Canadians do not? Our new research, published in the British ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Venova Technologies, Inc., a women-led startup developing a novel long-acting, hormone-free and copper-free female birth control device, has been awarded a $2.23M ...
When a teen girl recently posted on TikTok about the “pros and cons of birth control,” almost 120,000 people hit the “like” button. Of the pros, the girl said her birth control made her period ...
About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results